EUVIMEDEUVIMED entdecken
Crossref

Clinical significance of lncRNA EGFR-AS1 in gestational diabetes mellitus and its regulation of endothelial cell function

Hui Jiang, Pengcheng Wu, Min Zhang, Congxiang Liu

Irish Journal of Medical Science (1971 -) · 24.06.2026

DOI: 10.1007/s11845-026-04497-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 24.06.2026. Verfasst von Hui Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Guilin People's Hospital, Guilin City, Guangxi, China. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gestational diabetes mellitus (GDM) causes APOs. The diagnostic OGTT has a lag, and the role of lncRNA EGFR-AS1 in GDM has potential. AIMS: This study evaluated the potential of EGFR-AS1 for the GDM clinical application and explored the role of the EGFR-AS1/miR-142-5p/ROCK2 axis in placental endothelial injury. METHODS: Serum EGFR-AS1, miR-142-5p and ROCK2 levels were detected via qPCR in 135 GDM patients and 110 healthy pregnant women. The clinic value of EGFR-AS1 was analyzed using ROC and logistic regression. A high glucose (HG)-induced model was established, in which EGFR-AS1 was silenced alone or co-silenced with miR-142-5p. The regulatory mechanism of EGFR-AS1/miR-142-5p/ROCK2 axis on placental endothelial injury was then analyzed via CCK-8, ELISA, qPCR, and WB. RESULTS: In GDM patients, serum EGFR-AS1 and ROCK2 were elevated, whereas miR-142-5p was reduced. Serum EGFR-AS1 showed high diagnostic efficiency for GDM and acted as an independent predictor of APOs occurrence. Silencing EGFR-AS1 reversed HG-induced HPVECs injury-evidenced by inhibited inflammatory factor release, balanced oxidative stress, up-regulated pro-angiogenic factors mRNA expression, and down-regulated proteins expression related to apoptosis and endothelial injury. Dual-luciferase reporter assays confirmed binding between EGFR-AS1 and miR-142-5p, as well as between miR-142-5p and ROCK2. Notably, co-inhibiting EGFR-AS1 and miR-142-5p abolished the protective effect of EGFR-AS1 silencing. CONCLUSIONS: EGFR-AS1 is a clinical auxiliary biomarker for GDM diagnosis and prediction. It aggravates HPVECs injury via EGFR-AS1/miR-142-5p/ROCK2 axis, which impairs placental function and triggers APOs, providing a new target for GDM intervention.

Schlagwörter

Stichwörter der Autor:innen

Gestational diabetes mellitusLncRNAROCK2Vascular endothelial injurymiRNA

Autor:innen und Institutionen

  • Department of Obstetrics, Guilin People's Hospital, Guilin City, Guangxi, China.
  • Department of Obstetrics and Gynecology, Hospital Peoples of Daye City, Huangshi City, Hubei, 435100, China.
  • Department of Obstetrics and Gynecology, Suzhou BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Suzhou, Jiangsu, China.
  • West Hospital Third Ward, Obstetrics and Gynecology Hospital of Tongji University, 536 Changle Road, Shanghai, China. Liucongxiang881013@163.com.

Zitieren

APA

Jiang, H., Wu, P., Zhang, M., & Liu, C. (2026). Clinical significance of lncRNA EGFR-AS1 in gestational diabetes mellitus and its regulation of endothelial cell function. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-026-04497-7

Vancouver

Jiang H, Wu P, Zhang M, Liu C. Clinical significance of lncRNA EGFR-AS1 in gestational diabetes mellitus and its regulation of endothelial cell function. Irish Journal of Medical Science (1971 -). 2026. doi:10.1007/s11845-026-04497-7

BibTeX
@article{Jiang2026,
  author = {Jiang, Hui and Wu, Pengcheng and Zhang, Min and Liu, Congxiang},
  title = {Clinical significance of lncRNA EGFR-AS1 in gestational diabetes mellitus and its regulation of endothelial cell function},
  journal = {Irish Journal of Medical Science (1971 -)},
  year = {2026},
  doi = {10.1007/s11845-026-04497-7}
}
Kostenlos starten →